Quantum BioPharma is trading at $3.64 (up 8.98%), gaining alongside a broader biotech sector rally triggered by positive Moderna cancer-vaccine trial results that improved industry sentiment.
- The stock is recovering from a 9.24% decline on August 18, though no new company-specific catalysts were identified for today's session.
- Underlying sentiment remains supported by recent milestones, including narrowed Q2 expenses and recent FDA clearance for the Lucid-MS Phase 2 clinical trial.